Potential risk of TNF inhibitors on the progression of interstitial lung disease in patients with rheumatoid arthritis

OBJECTIVES: Biological therapy represents important advances in alleviating rheumatoid arthritis (RA), but the effect on interstitial lung disease (ILD) has been controversial. The objective of this study was to assess the risk of such treatment for patients with ILD. DESIGN: Case–control cohorts. S...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Nakashita, Tamao, Ando, Katsutoshi, Kaneko, Norihiro, Takahashi, Kazuhisa, Motojima, Shinji
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BMJ Publishing Group 2014
Gaiak:
Respiratory Medicine
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4139628/
https://ncbi.nlm.nih.gov/pubmed/25125479
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2014-005615
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak